These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28245414)

  • 1. [Advances of Studies on Platelet GPVI as Antithrombotic Target -Review].
    Li P; Qiao JL; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):264-269. PubMed ID: 28245414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet GPVI: a target for antithrombotic therapy?!
    Dütting S; Bender M; Nieswandt B
    Trends Pharmacol Sci; 2012 Nov; 33(11):583-90. PubMed ID: 22901552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein VI - novel target in antiplatelet medication.
    Borst O; Gawaz M
    Pharmacol Ther; 2021 Jan; 217():107630. PubMed ID: 32681846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Patients to Platelets and Back Again: Pharmacological Approaches to Glycoprotein VI, a Thrilling Antithrombotic Target with Minor Bleeding Risks.
    Martins Lima A; Martins Cavaco AC; Fraga-Silva RA; Eble JA; Stergiopulos N
    Thromb Haemost; 2019 Nov; 119(11):1720-1739. PubMed ID: 31564053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New advances in treating thrombotic diseases: GPVI as a platelet drug target.
    Jiang P; Jandrot-Perrus M
    Drug Discov Today; 2014 Sep; 19(9):1471-5. PubMed ID: 24931218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSK669, a NOD2 receptor antagonist, inhibits thrombosis and oxidative stress via targeting platelet GPVI.
    Pan G; Chang L; Zhang J; Liu Y; Hu L; Zhang S; Zhang J; Qiao J; Jakopin Ž; Hu H; Dong J; Ding Z
    Biochem Pharmacol; 2021 Jan; 183():114315. PubMed ID: 33152345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
    Degen H; Borst O; Ziegler M; Mojica Munoz AK; Jamasbi J; Walker B; Göbel S; Fassbender J; Adler K; Brandl R; Münch G; Lorenz R; Siess W; Gawaz M; Ungerer M
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redundancy and interaction of thrombin- and collagen-mediated platelet activation in tail bleeding and carotid thrombosis in mice.
    Bynagari-Settipalli YS; Cornelissen I; Palmer D; Duong D; Concengco C; Ware J; Coughlin SR
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2563-9. PubMed ID: 25278288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoprotein VI interplay with fibrin(ogen) in thrombosis.
    Mangin PH; Gardiner EE; Ariëns RAS; Jandrot-Perrus M
    J Thromb Haemost; 2023 Jul; 21(7):1703-1713. PubMed ID: 36990158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Glycoprotein VI and Its Downstream Signaling Pathways as an Antiplatelet Target.
    Fuentes E
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mechanistic concept of platelet inhibition.
    Sigalov AB
    Expert Opin Ther Targets; 2008 Jun; 12(6):677-92. PubMed ID: 18479215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond antiplatelets: The role of glycoprotein VI in ischemic stroke.
    Induruwa I; Jung SM; Warburton EA
    Int J Stroke; 2016 Aug; 11(6):618-25. PubMed ID: 27312676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of altered collagen-receptor functioning in platelets with emphasis on glycoprotein VI.
    Nurden AT
    Blood Rev; 2019 Nov; 38():100592. PubMed ID: 31351674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPVI inhibition: Advancing antithrombotic therapy in cardiovascular disease.
    Slater A; Khattak S; Thomas MR
    Eur Heart J Cardiovasc Pharmacother; 2024 Aug; 10(5):465-473. PubMed ID: 38453424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of glycoprotein VI as an antithrombotic target.
    Zahid M; Mangin P; Loyau S; Hechler B; Billiald P; Gachet C; Jandrot-Perrus M
    J Thromb Haemost; 2012 Dec; 10(12):2418-27. PubMed ID: 23020554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined in vivo depletion of glycoprotein VI and C-type lectin-like receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice.
    Bender M; May F; Lorenz V; Thielmann I; Hagedorn I; Finney BA; Vögtle T; Remer K; Braun A; Bösl M; Watson SP; Nieswandt B
    Arterioscler Thromb Vasc Biol; 2013 May; 33(5):926-34. PubMed ID: 23448972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Inhibition of Human Atherosclerotic Plaque-Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies.
    Jamasbi J; Megens RT; Bianchini M; Münch G; Ungerer M; Faussner A; Sherman S; Walker A; Goyal P; Jung S; Brandl R; Weber C; Lorenz R; Farndale R; Elia N; Siess W
    J Am Coll Cardiol; 2015 Jun; 65(22):2404-15. PubMed ID: 26046734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation.
    Mojica Muñoz AK; Jamasbi J; Uhland K; Degen H; Münch G; Ungerer M; Brandl R; Megens R; Weber C; Lorenz R; Siess W
    Thromb Haemost; 2017 Aug; 117(8):1651-1659. PubMed ID: 28569920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.
    Grüner S; Prostredna M; Aktas B; Moers A; Schulte V; Krieg T; Offermanns S; Eckes B; Nieswandt B
    Circulation; 2004 Nov; 110(18):2946-51. PubMed ID: 15505105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A humanized glycoprotein VI (GPVI) mouse model to assess the antithrombotic efficacies of anti-GPVI agents.
    Mangin PH; Tang C; Bourdon C; Loyau S; Freund M; Hechler B; Gachet C; Jandrot-Perrus M
    J Pharmacol Exp Ther; 2012 Apr; 341(1):156-63. PubMed ID: 22238212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.